- Home
- ONC vs CNP Comparison
ONC vs CNP Comparison
Compare ONC & CNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ONC | CNP |
|---|---|---|
| Founded | 2010 | 1866 |
| Country | Switzerland | United States |
| Employees | 12000 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 27.8B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | ONC | CNP |
|---|---|---|
| Price | $294.00 | $43.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | ★ $385.10 | $44.08 |
| AVG Volume (30 Days) | 178.0K | ★ 4.3M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.15% |
| EPS Growth | N/A | ★ 1.27 |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $9,357,000,000.00 |
| Revenue This Year | $723.76 | $7.02 |
| Revenue Next Year | $15.04 | $4.93 |
| P/E Ratio | $614.06 | ★ $91.03 |
| Revenue Growth | N/A | ★ 8.26 |
| 52 Week Low | $228.93 | $35.46 |
| 52 Week High | $385.22 | $44.47 |
Technical Indicators
Market Signals| Indicator | ONC | CNP |
|---|---|---|
| Relative Strength Index (RSI) | 41.83 | 54.10 |
| Support Level | $283.56 | $42.72 |
| Resistance Level | $300.00 | $44.30 |
| Average True Range (ATR) | 6.64 | 0.72 |
| MACD | -2.11 | 0.05 |
| Stochastic Oscillator | 11.89 | 67.32 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
About CNP CenterPoint Energy Inc (Holding Co)
CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio.